Purinergic signaling in early inflammatory events of the foreign body response: Modulating extracellular ATP as an enabling technology for engineered implants and tissues

Tissue Engineering - Part B: Reviews

Volumn 20, Issue 5, 2014, Pages 392-402

  Matthew Rhett, J ^a   Fann, Stephen A ^a   Yost, Michael J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINETRIPHOSPHATE; CELL DEATH; CELL SIGNALING; CONTROLLED DRUG DELIVERY; HISTOLOGY; IMPLANTS (SURGICAL); MAMMALS; METABOLITES; SIGNALING; TARGETED DRUG DELIVERY; TISSUE REGENERATION;

AUTOCRINE SIGNALING; CONDUCTIVE CHANNELS; ENABLING TECHNOLOGIES; FOREIGN BODY RESPONSE; IMPLANTED MEDICAL DEVICES; PEPTIDOMIMETIC DRUGS; PURINERGIC RECEPTORS; RESPONSE MECHANISMS;

TISSUE;

ABC TRANSPORTER; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; APYRASE; CONNEXIN 43; PEPTIDOMIMETIC AGENT; PURINERGIC P2X RECEPTOR; PURINERGIC P2Y RECEPTOR; PURINERGIC RECEPTOR;

CELL DEATH; EXOCYTOSIS; FOREIGN BODY; HEMOSTASIS; HUMAN; IMPLANTATION; MODULATION; NONHUMAN; REVIEW; TISSUE ENGINEERING; WOUND HEALING; ANIMAL; EXTRACELLULAR SPACE; FOREIGN BODY REACTION; INFLAMMATION; METABOLISM; PATHOLOGY; PROCEDURES; PROSTHESES AND ORTHOSES; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; EXTRACELLULAR SPACE; FOREIGN-BODY REACTION; HUMANS; INFLAMMATION; PROSTHESES AND IMPLANTS; RECEPTORS, PURINERGIC; SIGNAL TRANSDUCTION; TISSUE ENGINEERING;

EID: 84898887319     PISSN: 19373368     EISSN: 19373376     Source Type: Journal    
DOI: 10.1089/ten.teb.2013.0554     Document Type: Review

References (121)

1. Atala, A., Bauer, S.B., Soker, S., Yoo, J.J., and Retik, A.B. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 367, 1241, 2006.
2. Ashcroft, G.S., Yang, X., Glick, A.B., Weinstein, M., Letterio, J.L., Mizel, D.E., et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1, 260, 1999.
3. Martin, P., D'Souza, D., Martin, J., Grose, R., Cooper, L., Maki, R., et al. Wound healing in the PU.1 null mouse-tissue repair is not dependent on inflammatory cells. Curr Biol 13, 1122, 2003.
4. Qiu, C., Coutinho, P., Frank, S., Franke, S., Law, L.Y., Martin, P., et al. Targeting connexin43 expression accelerates the rate of wound repair. Curr Biol 13, 1697, 2003.
5. Lumelsky, N.L. Commentary: engineering of tissue healing and regeneration. Tissue Eng 13, 1393, 2007.
6. Mountziaris, P.M., and Mikos, A.G. Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev 14, 179, 2008.
7. Bryers, J.D., Giachelli, C.M., and Ratner, B.D. Engineering biomaterials to integrate and heal: the biocompatibility paradigm shifts. Biotechnology and bioengineering 109, 1898, 2012.
8. McNally, A.K., and Anderson, J.M. Macrophage fusion and multinucleated giant cells of inflammation. Adv Exp Med Biol 713, 97, 2011.
9. Brown, B.N., Ratner, B.D., Goodman, S.B., Amar, S., and Badylak, S.F. Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine. Biomaterials 33, 3792, 2012.
10. Jennette, J.C., Falk, R.J., Hu, P., and Xiao, H. Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Annu Rev Pathol 8, 139, 2013.
11. Burnstock, G. Purinergic signalling: its unpopular beginning, its acceptance and its exciting future. Bioessays 34, 218, 2012.
12. Abbracchio, M.P., Burnstock, G., Verkhratsky, A., and Zimmermann, H. Purinergic signalling in the nervous system: an overview. Trends Neurosci 32, 19, 2009.
13. Lohman, A.W., Billaud, M., and Isakson, B.E. Mechanisms of ATP release and signalling in the blood vessel wall. Cardiovasc Res 95, 269, 2012.
14. Anselmi, F., Hernandez, V.H., Crispino, G., Seydel, A., Ortolano, S., Roper, S.D., et al. ATP release through connexin hemichannels and gap junction transfer of second messengers propagate Ca2 + signals across the inner ear. Proc Natl Acad Sci U S A 105, 18770, 2008.
15. Braunstein, G.M., Roman, R.M., Clancy, J.P., Kudlow, B.A., Taylor, A.L., Shylonsky, V.G., et al. Cystic fibrosis transmembrane conductance regulator facilitates ATP release by stimulating a separate ATP release channel for autocrine control of cell volume regulation. J Biol Chem 276, 6621, 2001.
16. Clarke, T.C., Williams, O.J., Martin, P.E., and Evans, W.H. ATP release by cardiac myocytes in a simulated ischaemia model Inhibition by a connexin mimetic and enhancement by an antiarrhythmic peptide. Eur J Pharmacol 605, 9, 2008.
17. Orellana, J.A., Froger, N., Ezan, P., Jiang, J.X., Bennett, M.V., Naus, C.C., et al. ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels. J Neurochem 118, 826, 2011.
18. D'Hondt, C., Ponsaerts, R., Srinivas, S.P., Vereecke, J., and Himpens, B. Thrombin inhibits intercellular calcium wave propagation in corneal endothelial cells by modulation of hemichannels and gap junctions. Invest Ophthalmol Vis Sci 48, 120, 2007.
19. Gomes, P., Srinivas, S.P., Van Driessche, W., Vereecke, J., and Himpens, B. ATP release through connexin hemichannels in corneal endothelial cells. Invest Ophthalmol Vis Sci 46, 1208, 2005.
20. Decrock, E., De Vuyst, E., Vinken, M., Van Moorhem, M., Vranckx, K., Wang, N., et al. Connexin 43 hemichannels contribute to the propagation of apoptotic cell death in a rat C6 glioma cell model. Cell Death Differ 16, 151, 2008.
21. Holtzclaw, J.D., Cornelius, R.J., Hatcher, L.I., and Sansom, S.C. Coupled ATP and potassium efflux from intercalated cells. Am J Physiol Renal Physiol 300, F1319, 2011.
22. Lin, J.H., Lou, N., Kang, N., Takano, T., Hu, F., Han, X., et al. A central role of connexin 43 in hypoxic preconditioning. J Neurosci 28, 681, 2008.
23. Orellana, J.A., Shoji, K.F., Abudara, V., Ezan, P., Amigou, E., Saez, P.J., et al. Amyloid {beta}-induced death in neurons involves glial and neuronal hemichannels. J Neurosci 31, 4962, 2011.
24. Song, D., Liu, X., Liu, R., Yang, L., Zuo, J., and Liu, W. Connexin 43 hemichannel regulates H9c2 cell proliferation by modulating intracellular ATP and [Ca2 + ]. Acta Biochim Biophys Sin (Shanghai) 42, 472, 2010.
25. Stehberg, J., Moraga-Amaro, R., Salazar, C., Becerra, A., Echeverria, C., Orellana, J.A., et al. Release of gliotransmitters through astroglial connexin 43 hemichannels is necessary for fear memory consolidation in the basolateral amygdala. FASEB J 26, 3649, 2012.
26. Di Virgilio, F. Purines, purinergic receptors, and cancer. Cancer Res 72, 5441, 2012.
27. Burnstock, G., and Ulrich, H. Purinergic signaling in embryonic and stem cell development. Cell Mol Life Sci 68, 1369, 2011.
28. Burnstock, G., and Kennedy, C. P2X receptors in health and disease. Adv Pharmacol 61, 333, 2011.
29. Eltzschig, H.K., Sitkovsky, M.V., and Robson, S.C. Purinergic signaling during inflammation. N Engl J Med 367, 2322, 2012.
30. Yuan, D., Wang, Q., Wu, D., Yu, M., Zhang, S., Li, L., et al. Monocyte-endothelial adhesion is modulated by Cx43-stimulated ATP release from monocytes. Biochem Biophys Res Commun 420, 536, 2012.
31. McDonald, B., Pittman, K., Menezes, G.B., Hirota, S.A., Slaba, I., Waterhouse, C.C., et al. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 330, 362, 2010.
32. Davalos, D., Grutzendler, J., Yang, G., Kim, J.V., Zuo, Y., Jung, S., et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8, 752, 2005.
33. Chen, Y., Corriden, R., Inoue, Y., Yip, L., Hashiguchi, N., Zinkernagel, A., et al. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 314, 1792, 2006.
34. Lemaire, I., Falzoni, S., and Adinolfi, E. Purinergic signaling in giant cell formation. Front Biosci (Elite Ed) 4, 41, 2012.
35. Beis, I., and Newsholme, E.A. The contents of adenine nucleotides, phosphagens and some glycolytic intermediates in resting muscles from vertebrates and invertebrates. Biochem J 152, 23, 1975.
36. Dubyak, G.R., Clifford, E.E., Humphreys, B.D., Kertesy, S.B., and Martin, K.A. Expression of multiple ATP receptor subtypes during the differentiation and inflammatory activation of myeloid leukocytes. Drug Dev Res 39, 269, 1996.
37. Douglas, W.W., and Poisner, A.M. Evidence that the secreting adrenal chromaffin cell releases catecholamines directly from ATP-rich granules. J Physiol 183, 236, 1966.
38. Burnstock, G., and Noradrenaline and ATP: cotransmitters and neuromodulators. J Physiol Pharmacol 46, 365, 1995.
39. Irvin, J.L., and Irvin, E.M. The interaction of quinacrine with adenine nucleotides. J Biol Chem 210, 45, 1954.
40. Alund, M., and Olson, L. Depolarization-induced decreases in fluroescence intensity of gastro-intestinal quinacrine-binding nerves. Brain Res 166, 121, 1979.
41. Sawada, K., Echigo, N., Juge, N., Miyaji, T., Otsuka, M., Omote, H., et al. Identification of a vesicular nucleotide transporter. Proc Natl Acad Sci U S A. 105, 5683, 2008.
42. Fabbro, A., Skorinkin, A., Grandolfo, M., Nistri, A., and Giniatullin, R. Quantal release of ATP from clusters of PC12 cells. J Physiol 560, 505, 2004.
43. Lazarowski, E.R. Vesicular and conductive mechanisms of nucleotide release. Purinergic Signal 8, 359, 2012.
44. Bodin, P., and Burnstock, G. Purinergic signalling: ATP release. Neurochem Res 26, 959, 2001.
45. Fukuda, Y., and Schuetz, J.D. ABC transporters and their role in nucleoside and nucleotide drug resistance. Biochem Pharmacol 83, 1073, 2012.
46. Pier, G.B. The challenges and promises of new therapies for cystic fibrosis. J Exp Med 209, 1235, 2012.
47. Reisin, I.L., Prat, A.G., Abraham, E.H., Amara, J.F., Gregory, R.J., Ausiello, D.A., et al. The cystic fibrosis transmembrane conductance regulator is a dual ATP and chloride channel. J Biol Chem 269, 20584, 1994.
48. Tousson, A., Van Tine, B.A., Naren, A.P., Shaw, G.M., and Schwiebert, L.M. Characterization of CFTR expression and chloride channel activity in human endothelia. Am J Physiol 275, C1555, 1998.
49. Sprague, R.S., Ellsworth, M.L., Stephenson, A.H., Kleinhenz, M.E., and Lonigro, A.J. Deformation-induced ATP release from red blood cells requires CFTR activity. Am J Physiol 275, H1726, 1998.
50. Mattoscio, D., Evangelista, V., De Cristofaro, R., Recchiuti, A., Pandolfi, A., Di Silvestre, S., et al. Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response. FASEB J 24, 3970, 2010.
51. Tu, J., Le, G., and Ballard, H.J. Involvement of the cystic fibrosis transmembrane conductance regulator in the acidosis-induced efflux of ATP from rat skeletal muscle. J Physiol 588, 4563, 2010.
52. Laird, D.W. Life cycle of connexins in health and disease. Biochem J 394, 527, 2006.
53. Rhett, J.M., Jourdan, J., and Gourdie, R.G. Connexin 43 connexon to gap junction transition is regulated by zonula occludens-1. Mol Biol Cell 22, 1516, 2011.
54. Rhett, J.M., Ongstad, E.L., Jourdan, J., and Gourdie, R.G. Cx43 Associates with Na(v)1.5 in the Cardiomyocyte Perinexus. J Membr Biol 245, 411, 2012.
55. Gaietta, G., Deerinck, T.J., Adams, S.R., Bouwer, J., Tour, O., Laird, D.W., et al. Multicolor and electron microscopic imaging of connexin trafficking. Science 296, 503, 2002.
56. Saez, J.C., Berthoud, V.M., Branes, M.C., Martinez, A.D., and Beyer, E.C. Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev 83, 1359, 2003.
57. Panchin, Y., Kelmanson, I., Matz, M., Lukyanov, K., Usman, N., and Lukyanov, S. A ubiquitous family of putative gap junction molecules. Curr Biol 10, R473, 2000.
58. Penuela, S., Bhalla, R., Gong, X.Q., Cowan, K.N., Celetti, S.J., Cowan, B.J., et al. Pannexin 1 and pannexin 3 are glycoproteins that exhibit many distinct characteristics from the connexin family of gap junction proteins. J Cell Sci 120, 3772, 2007.
59. Bao, L., Locovei, S., and Dahl, G. Pannexin membrane channels are mechanosensitive conduits for ATP. FEBS Lett 572, 65, 2004.
60. Yagi, K., Shinbo, M., Hashizume, M., Shimba, L.S., Kurimura, S., and Miura, Y. ATP diphosphohydrolase is responsible for ecto-ATPase and ecto-ADPase activities in bovine aorta endothelial and smooth muscle cells. Biochem Biophys Res Commun 180, 1200, 1991.
61. Eltzschig, H.K., Eckle, T., Mager, A., Kuper, N., Karcher, C., Weissmuller, T., et al. ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function. Circ Res 99, 1100, 2006.
62. Kansas, G.S., Wood, G.S., and Tedder, T.F. Expression, distribution, and biochemistry of human CD39. Role in activation-associated homotypic adhesion of lymphocytes. J Immunol 146, 2235, 1991.
63. Thompson, L.F. Crucial role for Ecto-5′-nucleotidase (CD73) in vascular leakage during hypoxia. J Exp Med 200, 1395, 2004.
64. Hyman, M.C., Petrovic-Djergovic, D., Visovatti, S.H., Liao, H., Yanamadala, S., Bouis, D., et al. Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39. J Clin Invest 119, 1136, 2009.
65. Moser, G.H., Schrader, J., and Deussen, A. Turnover of adenosine in plasma of human and dog blood. Am J Physiol 256, C799, 1989.
66. Burnstock, G. Purine and pyrimidine receptors. Cell Mol Life Sci 64, 1471, 2007.
67. Kaczmarek-Hajek, K., Lorinczi, E., Hausmann, R., and Nicke, A. Molecular and functional properties of P2X receptors-recent progress and persisting challenges. Purinergic Signal 8, 375, 2012.
68. Solle, M., Labasi, J., Perregaux, D.G., Stam, E., Petrushova, N., Koller, B.H., et al. Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 276, 125, 2001.
69. Iyer, S.S., Pulskens, W.P., Sadler, J.J., Butter, L.M., Teske, G.J., Ulland, T.K., et al. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci U S A 106, 20388, 2009.
70. Ralevic, V., and Burnstock, G. Receptors for purines and pyrimidines. Pharmacol Rev 50, 413, 1998.
71. Rhett, J.M., Ghatnekar, G.S., Palatinus, J.A., O'Quinn, M., Yost, M.J., and Gourdie, R.G. Novel therapies for scar reduction and regenerative healing of skin wounds. Trends Biotechnol 26, 173, 2008.
72. Franz, S., Rammelt, S., Scharnweber, D., and Simon, J.C. Immune responses to implants-a review of the implications for the design of immunomodulatory biomaterials. Biomaterials 32, 6692, 2011.
73. Palatinus, J.A., Rhett, J.M., and Gourdie, R.G. Translational lessons from scarless healing of cutaneous wounds and regenerative repair of the myocardium. J Mol Cell Cardiol 48, 550, 2010.
74. Dovi, J.V., He, L.K., and DiPietro, L.A. Accelerated wound closure in neutrophil-depleted mice. J Leukoc Biol 73, 448, 2003.
75. Degen, K.E., and Gourdie, R.G. Embryonic wound healing: a primer for engineering novel therapies for tissue repair. Birth Defects Res C Embryo Today 96, 258, 2012.
76. Ghatnekar, G.S., O'Quinn, M.P., Jourdan, L.J., Gurjarpadhye, A.A., Draughn, R.L., and Gourdie, R.G. Connexin43 carboxyl-terminal peptides reduce scar progenitor and promote regenerative healing following skin wounding. Regen Med 4, 205, 2009.
77. O'Quinn, M.P., Palatinus, J.A., Harris, B.S., Hewett, K.W., and Gourdie, R.G. A Peptide mimetic of the connexin43 carboxyl terminus reduces gap junction remodeling and induced arrhythmia following ventricular injury. Circ Res 108, 704, 2011.
78. Soder, B.L., Propst, J.T., Brooks, T.M., Goodwin, R.L., Friedman, H.I., Yost, M.J., et al. The connexin43 carboxyl-terminal peptide ACT1 modulates the biological response to silicone implants. Plast Reconstr Surg 123, 1440, 2009.
79. Monroe, D.M., Hoffman, M., and Roberts, H.R. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 22, 1381, 2002.
80. Singer, A.J., and Clark, R.A. Cutaneous wound healing. N Engl J Med 341, 738, 1999.
81. Cote, Y.P., Filep, J.G., Battistini, B., Gauvreau, J., Sirois, P., and Beaudoin, A.R. Characterization of ATPdiphosphohydrolase activities in the intima and media of the bovine aorta: evidence for a regulatory role in platelet activation in vitro. Biochim Biophys Acta 1139, 133, 1992.
82. Komoszynski, M., and Wojtczak, A. Apyrases (ATP diphosphohydrolases, EC 3.6.1.5): function and relationship to ATPases. Biochim Biophys Acta 1310, 233, 1996.
83. Woulfe, D., Yang, J., and Brass, L. ADP and platelets: the end of the beginning. J Clin Invest 107, 1503, 2001.
84. Clark, R. Wound repair overview and general considerations. In: Clark, R., ed. The Molecular and Cellular Biology of Wound Repair. New York: Plenum Press, 1996, pp. 3-50.
85. Kahner, B.N., Shankar, H., Murugappan, S., Prasad, G.L., and Kunapuli, S.P. Nucleotide receptor signaling in platelets. J Thromb Haemost 4, 2317, 2006.
86. Burnstock, G., Knight, G.E., and Greig, A.V. Purinergic signaling in healthy and diseased skin. J Invest Dermatol 132, 526, 2012.
87. Godecke, S., Roderigo, C., Rose, C.R., Rauch, B.H., Godecke, A., and Schrader, J. Thrombin-induced ATP release from human umbilical vein endothelial cells. Am J Physiol Cell Physiol 302, C915, 2012.
88. Inkinen, K. Connective Tissue Formation in Wound Healing Department of Biosciences, University of Helsinki, Helsinki, [Academic Dissertation], Juhani Ahonen, Department of Surgery, Helsinki University Central Hospital, 2003. ISBN952-10-1313-3
89. Hubner, G., Brauchle, M., Smola, H., Madlener, M., Fassler, R., and Werner, S. Differential regulation of proinflammatory cytokines during wound healing in normal and glucocorticoid-treated mice. Cytokine 8, 548, 1996.
90. Tonnesen, M.G., Worthen, G.S., and Johnston, R.B.J. Neutrophil emigration, activation, and tissue damage. In: Clark, R.A.F., and Henson, P.M., eds. The Molecular and Cellular Biology of Wound Repair. New York: Plenum Press, 1988, pp. 149-183.
91. Chen, Y., Yao, Y., Sumi, Y., Li, A., To, U.K., Elkhal, A., et al. Purinergic signaling: a fundamental mechanism in neutrophil activation. Sci Signal 3, ra45, 2010.
92. Barletta, K.E., Ley, K., and Mehrad, B. Regulation of neutrophil function by adenosine. Arterioscler Thromb Vasc Biol 32, 856, 2012.
93. Zimmermann, H., and Braun, N. Extracellular metabolism of nucleotides in the nervous system. J Autonom Pharmacol 16, 397, 1996.
94. Ponsaerts, R., De Vuyst, E., Retamal, M., D'Hondt, C., Vermeire, D., Wang, N., et al. Intramolecular loop/tail interactions are essential for connexin 43-hemichannel activity. FASEB J 24, 4378, 2010.
95. Bodin, P., and Burnstock, G. Increased release of ATP from endothelial cells during acute inflammation. Inflamm Res 47, 351, 1998.
96. Wan, J., Ristenpart, W.D., and Stone, H.A. Dynamics of shear-induced ATP release from red blood cells. Proc Natl Acad Sci U S A 105, 16432, 2008.
97. Morais, J.M., Papadimitrakopoulos, F., and Burgess, D.J. Biomaterials/tissue interactions: possible solutions to overcome foreign body response. AAPS J 12, 188, 2010.
98. Robson, S.C., Candinas, D., Hancock, W.W., Wrighton, C., Winkler, H., and Bach, F.H. Role of endothelial cells in transplantation. Int Arch Allergy Immunol 106, 305, 1995.
99. Dormond, O., Dufour, M., Seto, T., Bruneau, S., and Briscoe, D.M. Targeting the intragraft microenvironment and the development of chronic allograft rejection. Hum Immunol 73, 1261, 2012.
100. Luttikhuizen, D.T., Harmsen, M.C., de Leij, L.F., and van Luyn, M.J. Expression of P2 receptors at sites of chronic inflammation. Cell Tissue Res 317, 289, 2004.
101. Varoni, E., Tschon, M., Palazzo, B., Nitti, P., Martini, L., and Rimondini, L. Agarose gel as biomaterial or scaffold for implantation surgery: characterization, histological and histomorphometric study on soft tissue response. Connect Tissue Res 53, 548, 2012.
102. Gilmartin, D.J., Alexaline, M.M., Thrasivoulou, C., Phillips, A.R., Jayasinghe, S.N., and Becker, D.L. Integration of scaffolds into full-thickness skin wounds: the connexin response. Adv Healthcare Mater 2, 1151, 2013.
103. Waldeck, H., Wang, X., Joyce, E., and Kao, W.J. Active leukocyte detachment and apoptosis/necrosis on PEG hydrogels and the implication in the host inflammatory response. Biomaterials 33, 29, 2012.
104. Spargo, B.J., Rudolph, A.S., and Rollwagen, F.M. Recruitment of tissue resident cells to hydrogel composites: in vivo response to implant materials. Biomaterials 15, 853, 1994.
105. Pol, B.J., van Wachem, P.B., van Luyn, M.J., van der Does, L., and Bantjes, A. In vivo testing of crosslinked polyethers. I. Tissue reactions and biodegradation. J Biomed Mater Res 32, 307, 1996.
106. Fann, S.A., Terracio, L., Yan, W., Franchini, J.L., and Yost, M.J. A model of tissue-engineered ventral hernia repair. J Invest Surg 19, 193, 2006.
107. Don, C.W., and Murry, C.E. Improving survival and efficacy of pluripotent stem cell-derived cardiac grafts. J Cell Mol Med 17, 1355, 2013.
108. Laflamme, M.A., and Murry, C.E. Heart regeneration. Nature 473, 326, 2011.
109. Laflamme, M.A., and Murry, C.E. Regenerating the heart. Nat Biotechnol 23, 845, 2005.
110. Terrovitis, J., Stuber, M., Youssef, A., Preece, S., Leppo, M., Kizana, E., et al. Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart. Circulation 117, 1555, 2008.
111. Mayfield, A.E., Tilokee, E.L., Latham, N., McNeill, B., Lam, B.K., Ruel, M., et al. The effect of encapsulation of cardiac stem cells within matrix-enriched hydrogel capsules on cell survival, post-ischemic cell retention and cardiac function. Biomaterials 35, 133, 2013.
112. Friedman, H.I., Friedman, A.C., and Carson, K. The fate of the fibrous capsule after saline implant removal. Ann Plast Surg 46, 215, 2001.
113. Bender, J.W., Friedman, H.I., Giurgiutiu, V., Watson, C., Fitzmaurice, M., and Yost, M.L. The use of biomedical sensors to monitor capsule formation around soft tissue implants. Ann Plast Surg 56, 72, 2006.
114. Komoszynski, M.A. Comparative studies on animal and plant apyrases (ATP diphosphohydrolase EC 3.6.1.5) with application of immunological techniques and various ATPase inhibitors. Comp Biochem Physiol B Biochem Mol Biol 113, 581, 1996.
115. Takahashi, T., Kimura, Y., Niwa, K., Ohmiya, Y., Fujimura, T., Yamasaki, K., et al. In vivo imaging demonstrates ATP release from murine keratinocytes and its involvement in cutaneous inflammation after tapestripping. J Invest Dermatol 133, 2407, 2013.
116. Amaral, S.S., Oliveira, A.G., Marques, P.E., Quintao, J.L., Pires, D.A., Resende, R.R., et al. Altered responsiveness to extracellular ATP enhances acetaminophen hepatotoxicity. Cell Commun Signal 11, 10, 2013.
117. Reutershan, J., Vollmer, I., Stark, S., Wagner, R., Ngamsri, K.C., and Eltzschig, H.K. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs. FASEB J 23, 473, 2009.
118. Tsai, T.L., Chang, S.Y., Ho, C.Y., and Kou, Y.R. Role of ATP in the ROS-mediated laryngeal airway hyperreactivity induced by laryngeal acid-pepsin insult in anesthetized rats. J Appl Physiol 106, 1584, 2009.
119. Idzko, M., Hammad, H., van Nimwegen, M., Kool, M., Willart, M.A., Muskens, F., et al. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med 13, 913, 2007.
120. Eckle, T., Fullbier, L., Wehrmann, M., Khoury, J., Mittelbronn, M., Ibla, J., et al. Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J Immunol 178, 8127, 2007.
121. Koyamada, N., Miyatake, T., Candinas, D., Hechenleitner, P., Siegel, J., Hancock, W.W., et al. Apyrase administration prolongs discordant xenograft survival. Transplantation 62, 1739, 1996.